Significant differences were observed between the serum TK1 levels in the group of patients with lymph node involvement and metastatic disease compared to those without, suggesting that the TK 210 ELISA can be used for prognosis as well as monitoring of breast cancer both in early and later stages of the disease. This evidence concerns the gene TK1 and breast carcinoma.